Trials / Active Not Recruiting
Active Not RecruitingNCT04499534
BRCA1/2 Flu Vaccine
Influenza Vaccine Study in BRCA1 or BRCA2 Carriers
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 25 Years
- Healthy volunteers
- Accepted
Summary
To evaluate immune function in BRCA1/2 mutation carriers without cancer, specifically to determine whether immune function in healthy individuals with germline loss of function BRCA1/2 mutations, impacts overall immune health and fitness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Seasonal influenza vaccine | To evaluate immune function in BRCA1/2 mutation carriers without cancer following seasonal influenza vaccination |
Timeline
- Start date
- 2019-10-28
- Primary completion
- 2026-03-01
- Completion
- 2026-06-01
- First posted
- 2020-08-05
- Last updated
- 2025-10-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04499534. Inclusion in this directory is not an endorsement.